theresa lavallee  celldex therapeutics  inc  zoominfocom theresa lavallee phd joins celldex therapeutics senior management team  marketwatch bulletin watch trump holds news conference with lebanons prime minister » investor alert new york markets close in market snapshot winners and losers press release dec    pm est theresa lavallee phd joins celldex therapeutics senior management team hampton nj dec   globe newswire via comtex  celldex therapeutics inc quoteszigmancomposite cldx  today announced that the company has hired theresa lavallee phd to the newly created position of senior vice president regulatory and precision medicine dr lavallee was previously senior vice president translational medicine and product development at kolltan pharmaceuticals which celldex recently acquired dr lavallee brings more than  years of industry experience in discovery and development of drug candidates in oncology and inflammation including extensive global regulatory experience and expertise in translational medicine to enable sciencedriven drug development dr lavallee played a critical role in developing and advancing the pipeline at kolltan pharmaceuticals and we felt it was important to bring her expertise inhouse to celldex said anthony marucci cofounder president and chief executive officer of celldex therapeutics in her new role theresa will continue to provide leadership to the receptor tyrosine kinase programs but will also reinforce our efforts in targeted drug development by assuming the leadership function for our precision medicine and regulatory activities we believe theresa is a valuable addition to our team and look forward to working with her celldex has been at the forefront of the precision medicine field identifying specific diseaserelated markers and developing targeted therapeutics to meet the needs of these distinct patient groups said theresa lavallee phd senior vice president regulatory and precision medicine while these initiatives combine the best of sciencebiomarker discovery companion diagnostics and drug developmentthey also bring an increasing level of complexity especially from a regulatory perspective i look forward to working with celldex to navigate these complexities and improve outcomes for patients dr lavallee joined kolltan in  most recently serving as senior vice president translational medicine and product development and was responsible for developing and executing the research and development strategy she established and expanded the companys translational medicine project management and development capabilities to transition kolltan from a preclinical to clinical stage company including leading the regulatory strategy behind these programs prior to kolltan dr lavallee held increasingly senior level roles at medimmuneastrazeneca and entremed dr lavallee started her career as a research scientist and has published extensively on her work throughout her career she received her phd in microbiology and molecular genetics from the university of california los angeles about celldex therapeutics inccelldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel diseasespecific therapies that induce enhance or suppress the bodys immune response visit wwwcelldexcom  forward looking statementthis release contains forwardlooking statements made pursuant to the safe harbor provisions of the private securities litigation reform act of  including those related to the companys strategic focus and the future development and commercialization by celldex and others of glembatumumab vedotin glemba cdx varlilumab varli cdx and other products and our goals for  forwardlooking statements reflect managements current knowledge assumptions judgment and expectations regarding future performance or events although management believes that the expectations reflected in such statements are reasonable they give no assurance that such expectations will prove to be correct or that those goals will be achieved and you should be aware that actual results could differ materially from those contained in the forwardlooking statements forwardlooking statements are subject to a number of risks and uncertainties including but not limited to our ability to successfully complete research and further development and commercialization of glembatumumab vedotin and other drug candidates our ability to obtain additional capital to meet our longterm liquidity needs on acceptable terms or at all including the additional capital which will be necessary to complete the clinical trials that we have initiated or plan to initiate our ability to successfully integrate our and kolltans business and to operate the combined businesses efficiently our ability to realize the anticipated benefits from the acquisition of kolltan the uncertainties inherent in clinical testing and accruing patients for clinical trials our limited experience in bringing programs through phase  clinical trials our ability to manage and successfully complete multiple clinical trials and the research and development efforts for our multiple products at varying stages of development the availability cost delivery and quality of clinical and commercial grade materials produced by our own manufacturing facility or supplied by contract manufacturers who may be our sole source of supply the timing cost and uncertainty of obtaining regulatory approvals our ability to maintain and derive benefit from the fast track designation for glembatumumab vedotin which does not change the standards for regulatory approval or guarantee regulatory approval on an expedited basis or at all the failure of the market for the companys programs to continue to develop our ability to protect the companys intellectual property the loss of any executive officers or key personnel or consultants competition changes in the regulatory landscape or the imposition of regulations that affect the companys products and other factors listed under risk factors in our annual report on form k and quarterly reports on form q all forwardlooking statements are expressly qualified in their entirety by this cautionary notice you are cautioned not to place undue reliance on any forwardlooking statements which speak only as of the date of this release we have no obligation and expressly disclaim any obligation to update revise or correct any of the forwardlooking statements whether as a result of new information future events or otherwise company contact sarah cavanaugh vice president of investor relations  corp communications celldex therapeutics inc   scavanaughcelldexcom charles liles associate director of investor relations  corp communications celldex therapeutics inc   clilescelldexcom media inquiries dan budwick brewlife   dbudwickbrewlifecom copyright c  globenewswire inc all rights reserved quoteszigmancomposite add to watchlist cldx celldex therapeutics inc us  us nasdaq     volume  july   p pe rationa dividend yieldna market cap million rev per employee most popular  the biggest dog in the dow might soon break free  need to know here’s why amazon facebook and the gang are not going to take down this market  market snapshot sp  nasdaq jump to record on bullish earnings even as alphabet weighs  one depressing reason millions of people are locked out of the american dream  fix your iphones old battery find a broker partner center » featured stories seeing america again through new eyes how to dig yourself out of debt move over tesla karma unveils its hybrid sports car the salary you need to afford a home in these  cities why opec will never cut production again log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pchipotle earnings media coverage of the latest illness scare will put earnings targets at risk phow an online wedding registry in my name appeared out of thin air pdicks sporting goods downgraded on concerns about ecommerce shift phere’s how trump could fire robert mueller the special counsel poil jumps to week high as opec raises hopes of market rebalancing pbarnes  noble stock jumps  after investor urges it to go private pnew revenue rules mean more work for companies big revenue for consultants and auditors pseagate technology downgraded to hold from buy at benchmark pwhat you can learn from jared kushner’s ad hoc approach to meetings phca’s weak quarter speaks to a longterm trend people are going to the doctor less p‘game of thrones’ science let’s take a closer look at that greyscale psenate votes to open debate on republican health bill as pence breaks tie p‘game of thrones’ the four biggest takeaways from stormborn’ ppence breaks deadlock in senate to proceed on healthcare bill ppence votes to break tie on motion to proceed psenate votes to open debate on republican healthcare bill pcaterpillar’s stock soars to more than year high as sales recession comes to an end pwhy oil prices scored their biggest oneday rally of  psen ron johnson votes in favor of motion to proceed pamd earnings how did we get here loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  theresa lavallee ph d joins celldex senior management team employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       theresa lavallee phd joins celldex cldx’ senior management team tweet   am   life sciences jobs     bullet newest jobs  last  hours   bullet california jobs   bullet massachusetts jobs   bullet new jersey jobs   bullet maryland jobs   bullet washington jobs   view more jobs hampton nj dec   globe newswire  celldex therapeutics inc nasdaqcldx today announced that the company has hired theresa lavallee phd to the newly created position of senior vice president regulatory and precision medicine dr lavallee was previously senior vice president translational medicine and product development at kolltan pharmaceuticals which celldex recently acquired dr lavallee brings more than  years of industry experience in discovery and development of drug candidates in oncology and inflammation including extensive global regulatory experience and expertise in translational medicine to enable sciencedriven drug development dr lavallee played a critical role in developing and advancing the pipeline at kolltan pharmaceuticals and we felt it was important to bring her expertise inhouse to celldex” said anthony marucci cofounder president and chief executive officer of celldex therapeutics in her new role theresa will continue to provide leadership to the receptor tyrosine kinase programs but will also reinforce our efforts in targeted drug development by assuming the leadership function for our precision medicine and regulatory activities we believe theresa is a valuable addition to our team and look forward to working with her” celldex has been at the forefront of the precision medicine field identifying specific diseaserelated markers and developing targeted therapeutics to meet the needs of these distinct patient groups” said theresa lavallee phd senior vice president regulatory and precision medicine “while these initiatives combine the best of science—biomarker discovery companion diagnostics and drug development—they also bring an increasing level of complexity especially from a regulatory perspective i look forward to working with celldex to navigate these complexities and improve outcomes for patients” dr lavallee joined kolltan in  most recently serving as senior vice president translational medicine and product development and was responsible for developing and executing the research and development strategy she established and expanded the company’s translational medicine project management and development capabilities to transition kolltan from a preclinical to clinical stage company including leading the regulatory strategy behind these programs prior to kolltan dr lavallee held increasingly senior level roles at medimmuneastrazeneca and entremed dr lavallee started her career as a research scientist and has published extensively on her work throughout her career she received her phd in microbiology and molecular genetics from the university of california los angeles about celldex therapeutics inccelldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel diseasespecific therapies that induce enhance or suppress the bodys immune response visit wwwcelldexcom forward looking statementthis release contains forwardlooking statements made pursuant to the safe harbor provisions of the private securities litigation reform act of  including those related to the companys strategic focus and the future development and commercialization by celldex and others of glembatumumab vedotin glemba cdx varlilumab varli cdx and other products and our goals for  forwardlooking statements reflect managements current knowledge assumptions judgment and expectations regarding future performance or events although management believes that the expectations reflected in such statements are reasonable they give no assurance that such expectations will prove to be correct or that those goals will be achieved and you should be aware that actual results could differ materially from those contained in the forwardlooking statements forwardlooking statements are subject to a number of risks and uncertainties including but not limited to our ability to successfully complete research and further development and commercialization of glembatumumab vedotin and other drug candidates our ability to obtain additional capital to meet our longterm liquidity needs on acceptable terms or at all including the additional capital which will be necessary to complete the clinical trials that we have initiated or plan to initiate our ability to successfully integrate our and kolltan’s business and to operate the combined businesses efficiently our ability to realize the anticipated benefits from the acquisition of kolltan the uncertainties inherent in clinical testing and accruing patients for clinical trials our limited experience in bringing programs through phase  clinical trials our ability to manage and successfully complete multiple clinical trials and the research and development efforts for our multiple products at varying stages of development the availability cost delivery and quality of clinical and commercial grade materials produced by our own manufacturing facility or supplied by contract manufacturers who may be our sole source of supply the timing cost and uncertainty of obtaining regulatory approvals our ability to maintain and derive benefit from the fast track designation for glembatumumab vedotin which does not change the standards for regulatory approval or guarantee regulatory approval on an expedited basis or at all the failure of the market for the companys programs to continue to develop our ability to protect the companys intellectual property the loss of any executive officers or key personnel or consultants competition changes in the regulatory landscape or the imposition of regulations that affect the companys products and other factors listed under risk factors in our annual report on form k and quarterly reports on form q all forwardlooking statements are expressly qualified in their entirety by this cautionary notice you are cautioned not to place undue reliance on any forwardlooking statements which speak only as of the date of this release we have no obligation and expressly disclaim any obligation to update revise or correct any of the forwardlooking statements whether as a result of new information future events or otherwisecompany contact sarah cavanaugh vice president of investor relations  corp communications celldex therapeutics inc   scavanaughcelldexcom charles liles associate director of investor relations  corp communications celldex therapeutics inc   clilescelldexcom media inquiries dan budwick brewlife   dbudwickbrewlifecom read at biospacecom related news celldex cldx presents data on cdx a novel cd agonist antibody for hematologic and solid malignancies at the american society of hematology annual meeting presidentelect trump set to debut dream team for healthcare reform little celldex cldx is sitting on plenty of cash and is ready to go shopping what the it’s trump celldex cldx takes out kolltan pharma in  million deal floundering socal biotech arrowhead pharma arwr fires cso effective later this month celldex cldx completes acquisition of kolltan pharma theranos cleans house gets rid of some highprofile board members celldex cldx presents data on new product candidate cdx a novel cd agonist antibody cytrx cytr plans to file nda for oncefailed sarcoma drug while columnist raises questions over efficacy and ceo salary amid struggle please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • celldex therapeutics inc   • biotechpharma  personnel                 theresa lavallee llc credit report products contacts florida search theresa lavallee llc company number l status inactive fei number  company type florida limited liability home state fl last activity date  date of incorporation  principal address  ne th st delray beach fl  mailing address  ne th st delray beach fl  theresa lavallee llc principals manager schappert kevin address  ne th st delray beach fl  last annual reports       registered agent agent name lavallee theresa n p agent address  ne th st delray beach fl  theresa lavallee llc events  admin dissolution for annual report fileddate  description theresa lavallee llc has been set up  in state fl the current status of the business is inactive the theresa lavallee llc principal adress is  ne th st delray beach fl  meanwhile you can send your letters to  ne th st delray beach fl  the companys registered agent is lavallee theresa n  ne th st delray beach fl  the companys management are manager  schappert kevin the last significant event in the company history is admin dissolution for annual report which is dated by  this decision is take in action on unknown the company annual reports filed on annual reports –  comprehensive report about this company view sample similar companies theresa leasing inc the resale association llc the resale connection inc the resale department inc theresa leigh soprano llc the resale network inc theresa lavallee phd joins celldex therapeutics’ senior management team nasdaqcldx english français register sign in theresa lavallee phd joins celldex therapeutics’ senior management team december    et  source celldex therapeutics inc hampton nj dec   globe newswire  celldex therapeutics inc nasdaqcldx today announced that the company has hired theresa lavallee phd to the newly created position of senior vice president regulatory and precision medicine dr lavallee was previously senior vice president translational medicine and product development at kolltan pharmaceuticals which celldex recently acquired dr lavallee brings more than  years of industry experience in discovery and development of drug candidates in oncology and inflammation including extensive global regulatory experience and expertise in translational medicine to enable sciencedriven drug development dr lavallee played a critical role in developing and advancing the pipeline at kolltan pharmaceuticals and we felt it was important to bring her expertise inhouse to celldex” said anthony marucci cofounder president and chief executive officer of celldex therapeutics in her new role theresa will continue to provide leadership to the receptor tyrosine kinase programs but will also reinforce our efforts in targeted drug development by assuming the leadership function for our precision medicine and regulatory activities we believe theresa is a valuable addition to our team and look forward to working with her” celldex has been at the forefront of the precision medicine field identifying specific diseaserelated markers and developing targeted therapeutics to meet the needs of these distinct patient groups” said theresa lavallee phd senior vice president regulatory and precision medicine “while these initiatives combine the best of science—biomarker discovery companion diagnostics and drug development—they also bring an increasing level of complexity especially from a regulatory perspective i look forward to working with celldex to navigate these complexities and improve outcomes for patients” dr lavallee joined kolltan in  most recently serving as senior vice president translational medicine and product development and was responsible for developing and executing the research and development strategy she established and expanded the company’s translational medicine project management and development capabilities to transition kolltan from a preclinical to clinical stage company including leading the regulatory strategy behind these programs prior to kolltan dr lavallee held increasingly senior level roles at medimmuneastrazeneca and entremed dr lavallee started her career as a research scientist and has published extensively on her work throughout her career she received her phd in microbiology and molecular genetics from the university of california los angeles about celldex therapeutics inccelldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel diseasespecific therapies that induce enhance or suppress the bodys immune response visit wwwcelldexcom forward looking statementthis release contains forwardlooking statements made pursuant to the safe harbor provisions of the private securities litigation reform act of  including those related to the companys strategic focus and the future development and commercialization by celldex and others of glembatumumab vedotin glemba cdx varlilumab varli cdx and other products and our goals for  forwardlooking statements reflect managements current knowledge assumptions judgment and expectations regarding future performance or events although management believes that the expectations reflected in such statements are reasonable they give no assurance that such expectations will prove to be correct or that those goals will be achieved and you should be aware that actual results could differ materially from those contained in the forwardlooking statements forwardlooking statements are subject to a number of risks and uncertainties including but not limited to our ability to successfully complete research and further development and commercialization of glembatumumab vedotin and other drug candidates our ability to obtain additional capital to meet our longterm liquidity needs on acceptable terms or at all including the additional capital which will be necessary to complete the clinical trials that we have initiated or plan to initiate our ability to successfully integrate our and kolltan’s business and to operate the combined businesses efficiently our ability to realize the anticipated benefits from the acquisition of kolltan the uncertainties inherent in clinical testing and accruing patients for clinical trials our limited experience in bringing programs through phase  clinical trials our ability to manage and successfully complete multiple clinical trials and the research and development efforts for our multiple products at varying stages of development the availability cost delivery and quality of clinical and commercial grade materials produced by our own manufacturing facility or supplied by contract manufacturers who may be our sole source of supply the timing cost and uncertainty of obtaining regulatory approvals our ability to maintain and derive benefit from the fast track designation for glembatumumab vedotin which does not change the standards for regulatory approval or guarantee regulatory approval on an expedited basis or at all the failure of the market for the companys programs to continue to develop our ability to protect the companys intellectual property the loss of any executive officers or key personnel or consultants competition changes in the regulatory landscape or the imposition of regulations that affect the companys products and other factors listed under risk factors in our annual report on form k and quarterly reports on form q all forwardlooking statements are expressly qualified in their entirety by this cautionary notice you are cautioned not to place undue reliance on any forwardlooking statements which speak only as of the date of this release we have no obligation and expressly disclaim any obligation to update revise or correct any of the forwardlooking statements whether as a result of new information future events or otherwisecompany contact sarah cavanaugh vice president of investor relations  corp communications celldex therapeutics inc   scavanaughcelldexcom charles liles associate director of investor relations  corp communications celldex therapeutics inc   clilescelldexcom media inquiries dan budwick brewlife   dbudwickbrewlifecom related articles other press releases by celldex therapeutics inc celldex therapeutics announces additions to the board of directors and senior management team june    celldex therapeutics to participate in the jefferies  global healthcare conference june    celldex therapeutics presents phase  study of varlilumab and opdivo® at  asco annual meeting june    celldex presents promising overall survival data from phase  study of singleagent glembatumumab vedotin in patients with checkpointrefractory metastatic melanoma june    celldex therapeutics to present clinical results at  asco annual meeting may    profile celldex therapeutics inc   subscribe via rss  subscribe via atom  javascript needham heights massachusetts united states contact data company contact sarah cavanaugh vice president of investor relations  corp communications celldex therapeutics inc   scavanaughcelldexcom charles liles associate director of investor relations  corp communications celldex therapeutics inc   clilescelldexcom media inquiries dan budwick brewlife   dbudwickbrewlifecom contact with a reader account its easy to send email directly to the contact for this release sign up today for your free reader account already have an account log in here media files celldex therapeutics inc logo logo url  copy the link below formats available original medium small newswire distribution network  management home newsroom rss feeds legal contact us about us globenewswire a nasdaq company is one of the worlds largest newswire distribution networks specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media investment community individual investors and the general public contact us corporate headquarters  rosecrans avenue suite  el segundo ca  phone   fax   european headquarters woolgate exchange  basinghall street london ecv ha uk phone     globenewswire inc all rights reserved theresa lavallee phd joins celldex therapeutics’ senior management team  pt community skip to main content pt community registersign in search form search home news ptcurrent issue past issues masthead digital edition subscribe pt tv authors about contact us   ingrezza® valbenazine tablets‎ zurampic® lesinurad tabletsplease click for full prescribing information including boxed warning you are herehome theresa lavallee phd joins celldex therapeutics’ senior management team hampton nj dec   globe newswire  celldex therapeutics inc nasdaqcldx today announced that the company has hired theresa lavallee phd to the newly created position of senior vice president regulatory and precision medicine dr lavallee was previously senior vice president translational medicine and product development at kolltan pharmaceuticals which celldex recently acquired dr lavallee brings more than  years of industry experience in discovery and development of drug candidates in oncology and inflammation including extensive global regulatory experience and expertise in translational medicine to enable sciencedriven drug development dr lavallee played a critical role in developing and advancing the pipeline at kolltan pharmaceuticals and we felt it was important to bring her expertise inhouse to celldex” said anthony marucci cofounder president and chief executive officer of celldex therapeutics in her new role theresa will continue to provide leadership to the receptor tyrosine kinase programs but will also reinforce our efforts in targeted drug development by assuming the leadership function for our precision medicine and regulatory activities we believe theresa is a valuable addition to our team and look forward to working with her” celldex has been at the forefront of the precision medicine field identifying specific diseaserelated markers and developing targeted therapeutics to meet the needs of these distinct patient groups” said theresa lavallee phd senior vice president regulatory and precision medicine “while these initiatives combine the best of science—biomarker discovery companion diagnostics and drug development—they also bring an increasing level of complexity especially from a regulatory perspective i look forward to working with celldex to navigate these complexities and improve outcomes for patients” dr lavallee joined kolltan in  most recently serving as senior vice president translational medicine and product development and was responsible for developing and executing the research and development strategy she established and expanded the company’s translational medicine project management and development capabilities to transition kolltan from a preclinical to clinical stage company including leading the regulatory strategy behind these programs prior to kolltan dr lavallee held increasingly senior level roles at medimmuneastrazeneca and entremed dr lavallee started her career as a research scientist and has published extensively on her work throughout her career she received her phd in microbiology and molecular genetics from the university of california los angeles about celldex therapeutics inccelldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel diseasespecific therapies that induce enhance or suppress the bodys immune response visit wwwcelldexcom forward looking statementthis release contains forwardlooking statements made pursuant to the safe harbor provisions of the private securities litigation reform act of  including those related to the companys strategic focus and the future development and commercialization by celldex and others of glembatumumab vedotin glemba cdx varlilumab varli cdx and other products and our goals for  forwardlooking statements reflect managements current knowledge assumptions judgment and expectations regarding future performance or events although management believes that the expectations reflected in such statements are reasonable they give no assurance that such expectations will prove to be correct or that those goals will be achieved and you should be aware that actual results could differ materially from those contained in the forwardlooking statements forwardlooking statements are subject to a number of risks and uncertainties including but not limited to our ability to successfully complete research and further development and commercialization of glembatumumab vedotin and other drug candidates our ability to obtain additional capital to meet our longterm liquidity needs on acceptable terms or at all including the additional capital which will be necessary to complete the clinical trials that we have initiated or plan to initiate our ability to successfully integrate our and kolltan’s business and to operate the combined businesses efficiently our ability to realize the anticipated benefits from the acquisition of kolltan the uncertainties inherent in clinical testing and accruing patients for clinical trials our limited experience in bringing programs through phase  clinical trials our ability to manage and successfully complete multiple clinical trials and the research and development efforts for our multiple products at varying stages of development the availability cost delivery and quality of clinical and commercial grade materials produced by our own manufacturing facility or supplied by contract manufacturers who may be our sole source of supply the timing cost and uncertainty of obtaining regulatory approvals our ability to maintain and derive benefit from the fast track designation for glembatumumab vedotin which does not change the standards for regulatory approval or guarantee regulatory approval on an expedited basis or at all the failure of the market for the companys programs to continue to develop our ability to protect the companys intellectual property the loss of any executive officers or key personnel or consultants competition changes in the regulatory landscape or the imposition of regulations that affect the companys products and other factors listed under risk factors in our annual report on form k and quarterly reports on form q all forwardlooking statements are expressly qualified in their entirety by this cautionary notice you are cautioned not to place undue reliance on any forwardlooking statements which speak only as of the date of this release we have no obligation and expressly disclaim any obligation to update revise or correct any of the forwardlooking statements whether as a result of new information future events or otherwisecontact company contact sarah cavanaugh vice president of investor relations  corp communications celldex therapeutics inc   scavanaughcelldexcom charles liles associate director of investor relations  corp communications celldex therapeutics inc   clilescelldexcom media inquiries dan budwick brewlife   dbudwickbrewlifecommonday december     stay in touch newsletters available pt and drug management daily news pt table of contents monthly contact us editorial j stephen mciver editoradvertising maureen dwyer liberti vice president group publisherproduction dawn flook director of production servicescirculation jackie ott circulation managerwebmaster webmaster industry announcements affimed presents data on firstinclass bcmatargeting immune cell engager afm at asco annual meeting  share buyback week  novartis drug tasigna receives eu approval for inclusion of treatmentfree remission tfr data in product label basilea announces presentation of interim phase a clinical data with anticancer drug candidate bal at asco meeting targovax presents further positive clinical data from tg phase iii trial at  asco annual meeting addex annual general meeting scheduled for  june  valneva to present at jefferies  global healthcare conference in new york targovax announces formal agenda for  capital markets updates in oslo and london lundbeck obtains rights to breakthrough research in alzheimer’s disease veloxis pharmaceuticals as announces agreement with chiesi farmaceutici spa to commercialize envarsus xr in china more from globe newswire current issue of pt july  user login username  password  create new account request new password theresa lavallee kolltan pharmaceuticals vp  product management profile subscribecontact us homeoverviewfree trialsubscribeservicesuse casesapi feedsreportsfaq tech executive download record   vcard  csv  pdf name   theresa lavallee title   vp  product management company name   kolltan pharmaceuticals company status   private  independent industry   biopharmaceutical profile   social media   company news   facebook   youtube   funding history   company transaction list mailing address    george st suite  new haven ct  usa  map phone     website   wwwkolltancom company description   kolltan is a developmentstage company advancing therapeutics that target welldefined and validated molecular mechanisms of disease in areas of critical clinical need investors   auven therapeuticsdeerfield capitalhbm biocapitalklp enterprisesosage partnerspurdue pharmatichenor venturesundisclosed free trial want unlimited access to the complete database with thousands of technology companies vcs and transactions for only  per month start your free  day trial now – no obligation or credit card required about venturedeal founded in  venturedeal is a database that provides the latest information about venture capital firms venturebacked technology companies and transactions throughout north america learn more » home overview service firms tech entrepreneurs venture investors services subscribe use cases faq terms of use privacy policy contact login  venturedeal inc menlo park ca all rights reserved microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming we also search social networks this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip